Literature DB >> 10760956

Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms.

S Kon1, M Maeda, T Segawa, Y Hagiwara, Y Horikoshi, S Chikuma, K Tanaka, M M Rashid, M Inobe, A F Chambers, T Uede.   

Abstract

We have generated synthetic peptides corresponding to various portions of human osteopontin (OPN) and have immunized rabbits and mice with these peptides to generate polyclonal and monoclonal antibodies specific to human OPN. We then generated six distinct sandwich enzyme-linked immunoabsorbent assay (ELISA) systems by using different pairs of polyclonal and monoclonal antibodies against human OPN. These systems allowed us to detect not only various isoforms and truncated forms of recombinant OPN, but also the glycosylated form of native urinary OPN. Most importantly, tumor-derived OPN was differentially detected by the six ELISA systems. The ELISA systems that we have developed will be useful for clarifying the functional roles for OPN in vivo in various physiologic and pathologic conditions. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760956

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  21 in total

1.  Prevention of the cryptic epitope SLAYGLR within osteopontin does not influence susceptibility to Candida albicans infection.

Authors:  Ikuko Sato; Nobuchika Yamamoto; Harumi Yamazaki; Seiji Hashimoto; Motohiro Hino; Fumihiko Sakai; Akihiko Fujie
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  The novel α4B murine α4 integrin protein splicing variant inhibits α4 protein-dependent cell adhesion.

Authors:  Hitomi Kouro; Shigeyuki Kon; Naoki Matsumoto; Tomoe Miyashita; Ayaka Kakuchi; Dai Ashitomi; Kodai Saitoh; Takuya Nakatsuru; Sumihito Togi; Ryuta Muromoto; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

3.  Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.

Authors:  Lalita A Shevde; Rajeev S Samant; Jason C Paik; Brandon J Metge; Ann F Chambers; Graham Casey; Andra R Frost; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

4.  Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.

Authors:  T Sato; T Nakai; N Tamura; S Okamoto; K Matsuoka; A Sakuraba; T Fukushima; T Uede; T Hibi
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 5.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

6.  The first intron of the human osteopontin gene contains a C/EBP-beta-responsive enhancer.

Authors:  Francesca Giacopelli; Nadia Rosatto; Maria Teresa Divizia; Roberto Cusano; Gianluca Caridi; Roberto Ravazzolo
Journal:  Gene Expr       Date:  2003

7.  The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems.

Authors:  Yasuto Kunii; Shin-ichi Niwa; Yoshiaki Hagiwara; Masahiro Maeda; Tsutomu Seitoh; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

8.  Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.

Authors:  Jennifer Sullivan; Laurel Blair; Amer Alnajar; Tamer Aziz; Chee Yuan Ng; Galina Chipitsyna; Qiaoke Gong; Agnes Witkiewicz; Georg F Weber; David T Denhardt; Charles J Yeo; Hwyda A Arafat
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.

Authors:  Lauren A Thurgood; Phulwinder K Grover; Rosemary Lyons Ryall
Journal:  Urol Res       Date:  2008-05-14

10.  Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells.

Authors:  Mari L Shinohara; Hye-Jung Kim; June-Ho Kim; Virgilio A Garcia; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.